awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28534786-0F778BF3-B34E-4D2C-8543-394C1EDC38D2
Q28534786-0F778BF3-B34E-4D2C-8543-394C1EDC38D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-0F778BF3-B34E-4D2C-8543-394C1EDC38D2
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial
P2860
Q28534786-0F778BF3-B34E-4D2C-8543-394C1EDC38D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-0F778BF3-B34E-4D2C-8543-394C1EDC38D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8c9fd18b61fce059f61f1aefd97128b29c06f33
P2860
Beyond taxanes: the next generation of microtubule-targeting agents